Brain – V9: 2023+
| Primary Site | Histology | Behavior | Year of Diagnosis |
|---|---|---|---|
| C700, C710-C719 | 8000-8803, 8810-8858, 8860-8900, 8902-8905, 8921, 8932-8934, 8940-8990, 8992, 9000-9016, 9030-9043, 9045-9221, 9230, 9240-9361, 9363-9365, 9370-9460, 9480-9500, 9505-9507, 9509-9580, 9582 | 3 | 2023-9998, 9999, <BLANK> |
| C700, C710-C719 | 8000-9582 | 0, 1 | 2023-9998, 9999, <BLANK> |
Notes
**See table above for primary sites and histologies for this schema** C700: Cerebral meninges C710: Cerebrum C711: Frontal lobe C712: Temporal lobe C713: Parietal lobe C714: Occipital lobe C715: Ventricle, NOS C716: Cerebellum, NOS C717: Brain stem C718: Overlapping lesion of brain C719: Brain, NOS **Note 1:** **Sources used in the development of this schema** * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Brain and Spinal Cord, from the AJCC Cancer Staging System Version 9 (2022). Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** **Other EOD Schemas with Brain sites** * All histologies with behavior /0 and /1 are captured in this schema, for behavior /3, see the following schemas for the listed histologies * **GIST**: 8935-8936 * **Soft Tissue Rare**: 8804-8806, 8859, 8901, 8910-8920, 8930-8931, 8991, 9020, 9044, 9222, 9231, 9366-9368, 9581 **Note 3:** **Medulloblastoma** * For diagnoses January 1, 2023, and forward, the following histologies will be collected in the Medulloblastoma EOD schema * 9362, 9470-9478, 9501-9504, 9508 **Note 4:** **Summary Stage** * Summary Stage is the only applicable staging system for this site/histology/schema.Data Items
| Name | Default Value | Used in Derivation | NAACCR Item | Required By | Metadata |
|---|---|---|---|---|---|
| Year of Diagnosis | Yes |
NAACCR #390
dateOfDiagnosis |
None | ||
| Primary Site | Yes |
NAACCR #400
primarySite |
None | ||
| Histology | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | ||
| Behavior | Yes |
NAACCR #523
behaviorCodeIcdO3 |
None | ||
| Type of Reporting Source | No |
NAACCR #500
typeOfReportingSource |
None | ||
| Tumor Size Clinical | No |
NAACCR #752
tumorSizeClinical |
None | ||
| Tumor Size Pathological | No |
NAACCR #754
tumorSizePathologic |
None | ||
| Tumor Size Summary | 999 | No |
NAACCR #756
tumorSizeSummary |
None | |
| Regional Nodes Positive | 99 | No |
NAACCR #820
regionalNodesPositive |
None | |
| Regional Nodes Examined | 99 | No |
NAACCR #830
regionalNodesExamined |
None | |
| EOD Primary Tumor | 999 | Yes |
NAACCR #772
eodPrimaryTumor |
None | |
| EOD Regional Nodes | 888 | Yes |
NAACCR #774
eodRegionalNodes |
None | |
| EOD Mets | 00 | Yes |
NAACCR #776
eodMets |
None | |
| SS2018 | No |
NAACCR #764
summaryStage2018 |
None | ||
| Grade Clinical | 9 | Yes |
NAACCR #3843
gradeClinical |
All | SSDI |
| Grade Pathological | 9 | Yes |
NAACCR #3844
gradePathological |
All | SSDI |
| Grade Post Therapy Clin (yc) | No |
NAACCR #1068
gradePostTherapyClin |
COC NPCR SEER |
SSDI | |
| Grade Post Therapy Path (yp) | No |
NAACCR #3845
gradePostTherapy |
CCCR/Canada COC NPCR SEER |
SSDI | |
| Brain Molecular Markers | 88 | No |
NAACCR #3816
brainMolecularMarkers |
NPCR SEER |
SSDI |
| Chromosome 1p Status | 8 | No |
NAACCR #3801
chromosome1pLossHeterozygosity |
COC SEER |
SSDI |
| Chromosome 19q Status | 8 | No |
NAACCR #3802
chromosome19qLossHeterozygosity |
COC SEER |
SSDI |
| MGMT | 8 | No |
NAACCR #3889
methylationOfO6MGMT |
COC SEER |
SSDI |
| Neoadjuvant Therapy | 9 | No |
NAACCR #1632
neoadjuvantTherapy |
SEER 2021– | SSDI 2021– |
| Neoadjuvant Therapy – Clinical Response | 99 | No |
NAACCR #1633
neoadjuvTherapyClinicalResponse |
SEER 2021– | SSDI 2021– |
| Neoadjuvant Therapy – Treatment Effect | 9 | No |
NAACCR #1634
neoadjuvTherapyTreatmentEffect |
SEER 2021– | SSDI 2021– |
| Brain Primary Tumor Location | No |
NAACCR #3964
brainPrimaryTumorLocation |
CCCR/Canada 2024– COC 2024– NPCR 2024– SEER 2024– |
SSDI 2024– |
Initial Context
Outputs
| Name | Default Value | Description | NAACCR Item | Metadata |
|---|---|---|---|---|
| Schema ID | 09721 |
NAACCR #3800
schemaId |
None | |
| Derived Version | {{ctx_alg_version}} | None | None | |
| Derived Summary Stage 2018 | 9 |
NAACCR #762
derivedSummaryStage2018 |
None | |
| Derived Summary Grade 2018 | <BLANK> |
NAACCR #1975
derivedSummaryGrade2018 |
None |